Silver Book

Silver Book Fact

Pulmonary hypertension is a complication in at least 23% of patients with significant mitral regurgitation due to flail leaflet, and approximately doubles the risk of death and heart failure after diagnosis.

Barbieri A, Bursi F, Grigioni F, et al. Prognostic and Therapeutic Implications of Pulmonary Hypertension Complicating Degenerative Mitral Regurgitation Due to Flail Leaflet. Eur Heart J. 2011; 32(6). https://www.ncbi.nlm.nih.gov/pubmed/20829213

Reference

Title
Prognostic and Therapeutic Implications of Pulmonary Hypertension Complicating Degenerative Mitral Regurgitation Due to Flail Leaflet
Publication
Eur Heart J
Publication Date
2011
Authors
Barbieri A, Bursi F, Grigioni F, et al
Volume & Issue
Volume 32, Issue 6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Publications

Silver Book: Valve Disease Volume

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-Vol-TN.jpg Thumbnail

Related Facts

  • Heart disease costs the U.S. $108.9 billion a year–including direct medical expenses and indirect cost in lost of productivity.  
  • Hospitalization costs for patients with nonrecurrent ischemic stroke
    The cost of hospitalization for patients with nonrecurrent ischemic stroke is $4,991 more in patients with atrial fibrillation, than in patients without the disease.        
  • Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.
     
  • People who have had a myocardial infarction have a sudden death rate that is 4 to 6 times higher than the general public.  
  • Every year since 1900 (except 1918), cardiovascular disease accounted for more deaths than any other single or group of causes of death in the United States.